Artificial IntelligenceNCT07722208
AI Chatbots Versus Classroom Attendance Implications for Learning Outcomes and CGPA Among Physical Therapy Students
A study testing GCPA in people with Artificial Intelligence, run by October 6 University at 1 site in Egypt.
Trial summary
Artificial intelligence-powered chatbots (AI-PCs) are increasingly integrated into educational settings, including health care disciplines. Despite their potential to enhance learning, limited research has investigated physiotherapy (PT) students' acceptance of this technology. Read more about this study
- Who is it for?
- Ages 18 to 35 years
- Conditions the study is for
- Artificial Intelligence
- What is being tested?
- GCPA
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jan 2026to 20 Jun 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Student
- Age not less than 18 years
- Regular student on his university
Who cannot join
- Irregular student
- Students failed in many semester
Trial locations and contacts
1 site in 1 country.
About this study
Artificial intelligence-powered chatbots (AI-PCs) are increasingly integrated into educational settings, including health care disciplines. Despite their potential to enhance learning, limited research has investigated physiotherapy (PT) students' acceptance of this technology.
- Conditions
- Artificial Intelligence
- Being tested
- GCPA
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
GCPAOther
Calculate GCPA at the end of semester
| Study group | Role | What they receive |
|---|---|---|
| Student learning on AI chatbots | Experimental | Student has been absent from university and all of our lectures and learning from AI chat bots Receives: Other: GCPA |
| Student learning from attendance of lectures on University | Experimental | Student learning from attendance of lectures on university and they don't use Ai chatbots Receives: Other: GCPA |
What is being measured
The primary outcome is the main question the study is designed to answer.
GCPA
Calculate GPA at the end of semester
Measured: 3 months which will start at the beginning of semester
Attendance
Attendance of students at beginning of semester
Measured: 3 months which will start at the beginning of semester
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jul 2026
- Study start1 Jan 2026
- Primary completion28 Apr 2026
- Study completion20 Jun 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Artificial IntelligenceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- October 6 University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kerolous Ishak Shehata, October 6 University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07722208
- Sponsor's protocol ID
- IRB#14\7\2025-2026
- Status last verified
- Jul 2026
- First submitted
- 19 Jul 2026
- Last updated
- 23 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- AI Chatbots Versus Classroom Attendance Implications for Learning Outcomes and CGPA Among Physical Therapy Students
- ClinicalTrials.gov ID
- NCT07722208
- Acronym / sponsor ID
- IRB#14\7\2025-2026
- Conditions
- Artificial Intelligence
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- October 6 UniversityUniversity, hospital or other
- Study start
- 1 Jan 2026 (actual)
- Primary completion
- 28 Apr 2026 (actual)
- Study completion
- 20 Jun 2026 (actual)
- First posted
- 23 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Artificial intelligence-powered chatbots (AI-PCs) are increasingly integrated into educational settings, including health care disciplines. Despite their potential to enhance learning, limited research has investigated physiotherapy (PT) students' acceptance of this technology.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Student learning on AI chatbots | Experimental | Other: GCPAStudent has been absent from university and all of our lectures and learning from AI chat bots |
| Student learning from attendance of lectures on University | Experimental | Other: GCPAStudent learning from attendance of lectures on university and they don't use Ai chatbots |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Student
- Age not less than 18 years
- Regular student on his university
Key exclusion criteria (2 listed)
- Irregular student
- Students failed in many semester
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| GCPACalculate GCPA at the end of semester | Other | Student learning from attendance of lectures on University, Student learning on AI chatbots |
Primary outcome
GCPA
Time frame: 3 months which will start at the beginning of semester
Calculate GPA at the end of semester
Attendance
Time frame: 3 months which will start at the beginning of semester
Attendance of students at beginning of semester
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jul 2026.
Related trials for Artificial Intelligence
Not yet recruiting
Impact of Generative AI on University Students' Learning Processes and Critical Thinking
Education, Academic Performance
Active, not recruiting
AI Ambient Scribe in Psychiatry
Therapeutic Alliance, Empathy
Not yet recruiting
Social Software-Based Intelligent Management System for Bowel Preparation
Colorectal Polyp, Colorectal Adenoma
RecruitingObservational study
Artificial Intelligence for Automated Clinical Data Exploration From Electronic Medical Records (CardioMining-AI)
Artificial Intelligence, Machine Learning
Not yet recruiting
AI-Driven Video Avatars vs. Customized GPTs: Professional English Learning Among Nursing Students
Artifical Intelligence, Generative Artificial Intelligence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing GCPA in people with Artificial Intelligence, run by October 6 University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
GCPA (time frame: 3 months which will start at the beginning of semester). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2026; AzTrials last refreshed its copy on 29 Oct 2026.